Accelerating the Implementation of Technology in the Clinical Lab



The MSACL Organization

CMS Journal Management


Alan Rockwood
University of Utah / ARUP Laboratories
Salt Lake City, Utah, United States

Alan Rockwood, PhD, DABCC is Professor of Pathology at the University of Utah School of Medicine and Scientific Director, Mass Spectrometry Laboratory, at ARUP Laboratories in Salt Lake City, Utah, USA. Originally trained in Physical Chemistry, he performed research on the fundamentals of mass spectrometry and instrumentation development before focusing his career on Clinical Chemistry. He is certified by the American Board of Clinical Chemistry and holds a Certificate of Qualification in Clinical Chemistry from the New York State Board of Health. Currently, his primary area of research is the development of mass spectrometry-based quantitative assays for targeted analytes of clinical interest, including small molecules and more recently proteins and peptides. Additionally, he maintains a smaller research effort on fundamentals of mass spectrometry, particularly novel approaches for isotopic profile calculations. He has published >150 papers in peer reviewed journals.

Michael Vogeser
Ludwig-Maximilians-Universität München (LMU)
München, Germany

Dr. Michael Vogeser, MD, is specialist in Laboratory Medicine and senior physician at the Hospital of the University of the Ludwig-Maximilians-University Munich, Germany (Institute of Laboratory Medicine). As an Associate Professor he is teaching Clinical Chemistry and Laboratory Medicine. The main scope of his scientific work is the application of mass spectrometric technologies in routine clinical laboratory testing as translational diagnostics. Besides method development in therapeutic drug monitoring and endocrinology a further particular field of his work is quality and risk management in mass spectrometry and in clinical testing in general. Michael has published >150 articles in peer reviewed medical journals and is secretary of the German Association of Clinical Chemistry and Laboratory Medicine (DGKL) (2016 – 2019).

Managing Editor

Chris Herold
Del Mar, California, United States

Chris Herold, PhD, MBA, is a scientifically-trained entrepreneur. He received his undergraduate degree in Chemical Engineering at the University of Virginia, after which he left the US to spend nine months in Lausanne, Switzerland, at Scitec SA working on a Perkin Elmer Q-Mass quadrupole to analyze soil and water samples for toxic components. He returned to the US and completed his doctorate in Molecular Pathology at the University of California, San Diego (UCSD) and then pursued his interest in entrepreneurship joining the start-up, Prediction Sciences (PS). While at PS he wrote and directed SBIR grants from the NIH and NSF as Principal Investigator with the goal of identifying correlations between SNP profiles and drug response (pharmacogenomics). He left PS to pursue an MBA from Cornell University in Entrepreneurship and then joined the start-up Arrayomics, which focused on the development of microarray technology. He is a founding board member of MSACL and, as President & COO, has been responsible for its operational logistics since the organization's inception.